Advertisement
Screener

InspireMD, Inc. (NSPR) Payments to Acquire Marketable Securities

2.8 / 5 stars · 68/120 Roast Me

InspireMD, Inc. Payments to Acquire Marketable Securities

InspireMD, Inc. (NSPR) reported Payments to Acquire Marketable Securities of $56.84 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-14

  • InspireMD, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $45.09M.
  • InspireMD, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • InspireMD, Inc. payments to acquire marketable securities for the quarter ending 2025-06-30 was $4.84M.
  • InspireMD, Inc. payments to acquire marketable securities for the quarter ending 2025-03-31 was $6.91M, a 252.50% increase year-over-year.
  • InspireMD, Inc. payments to acquire marketable securities for fiscal 2025 was $56.84M, a 293.52% increase from fiscal 2024.
  • InspireMD, Inc. payments to acquire marketable securities for fiscal 2024 was $14.44M, a 58.31% decline from fiscal 2023.
  • InspireMD, Inc. payments to acquire marketable securities for fiscal 2023 was $34.64M.
Period endPayments to Acquire Marketable Securities 3 monthPayments to Acquire Marketable Securities 6 monthPayments to Acquire Marketable Securities 9 monthPayments to Acquire Marketable Securities 12 month
2025-12-31$45.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$45.09M
derived: sum of 2 quarters · filed 2026-03-18
$49.93M
derived: sum of 3 quarters · filed 2026-08-14
$56.84M
10-K · filed 2026-03-18
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$4.84M
derived: sum of 2 quarters · filed 2026-08-14
$11.75M
10-Q · filed 2025-11-10
$11.75M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$4.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$11.75M
10-Q · filed 2026-08-14
$11.75M
derived: sum of 3 quarters · filed 2026-08-14
$24.23M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$6.91M
10-Q · filed 2026-05-07
$6.91M
derived: sum of 2 quarters · filed 2026-05-07
$19.39M
derived: sum of 3 quarters · filed 2026-05-07
$19.39M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$12.48M
derived: sum of 2 quarters · filed 2026-03-18
$12.48M
derived: sum of 3 quarters · filed 2026-03-18
$14.44M
10-K · filed 2026-03-18
2024-09-30$12.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$12.48M
derived: sum of 2 quarters · filed 2025-11-10
$14.44M
10-Q · filed 2025-11-10
$20.25M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$1.96M
10-Q · filed 2025-08-04
$7.77M
derived: sum of 3 quarters · filed 2025-08-04
$7.77M
derived: sum of 4 quarters · filed 2025-08-04
2024-03-31$1.96M
10-Q · filed 2025-05-08
$7.77M
derived: sum of 2 quarters · filed 2025-05-08
$7.77M
derived: sum of 3 quarters · filed 2025-05-08
2023-12-31$5.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
$5.81M
derived: sum of 2 quarters · filed 2025-03-12
$34.64M
10-K · filed 2025-03-12
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$28.84M
10-Q · filed 2024-11-12
2023-06-30$28.84M
10-Q · filed 2024-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
NEPHROS INC (NEPH)United States$0.046B23.02
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24